Volume 4, number 2
 Views: (Visited 148 times, 1 visits today)    PDF Downloads: 913

Pawar P. Y, Kaskhedikar S. G. Synthesis and in vitro screening of some 1,3,4-oxadiazole derivatives as lipoxygenase inhibitors. Biosci Biotechnol Res Asia 2007;4(2)
Manuscript received on : August 23, 2007
Manuscript accepted on : October 16, 2007
Published online on:  03-02-2016
How to Cite    |   Publication History    |   PlumX Article Matrix

Synthesis and in vitro screening of some 1,3,4-oxadiazole derivatives as lipoxygenase inhibitors

P. Y. Pawar1* and S. G. Kaskhedikar2

1Department of Pharmchemistry, P.D.V.V.P.F’s College of Pharmacy, Vilad Ghat, Ahmednagar - 414 111, (India). 2Department of Pharmacy, S.G.S.I.TS., 23 Park Road, Vallabhnagar, Indore - 03, (India).

ABSTRACT: 1,3,4-oxadiazole derivatives of some classical Non Steroidal Anti-inflammatory Drugs were synthesized and investigated for the lipoxygenase inhibitory activity in vitro. The target compounds were obtained by cyclodesulfurization of the corresponding thiosemicarbazides using I2/NaOH. The intermediates were readily accessible through conversion of the carboxylic acid group to the respective acid hydrazides followed by treatment with phenyl isothiocyanate to yield corresponding thiosemicarbazides. The constitution of the products was confirmed by spectroscopic and elemental analysis. All the synthesized oxadiazole derivatives exhibited significant lipoxygenase inhibitory activity.

KEYWORDS: 1,3,4-oxadiazole; Lipoxygenase inhibition; NSAIDs

Download this article as: 
Copy the following to cite this article:

Pawar P. Y, Kaskhedikar S. G. Synthesis and in vitro screening of some 1,3,4-oxadiazole derivatives as lipoxygenase inhibitors. Biosci Biotechnol Res Asia 2007;4(2)

Copy the following to cite this URL:

Pawar P. Y, Kaskhedikar S. G. Synthesis and in vitro screening of some 1,3,4-oxadiazole derivatives as lipoxygenase inhibitors. Biosci Biotechnol Res Asia 2007;4(2). Available from: https://www.biotech-asia.org/?p=6010

(Visited 148 times, 1 visits today)

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.